IP Library › Granted Patent US 12,507,920
Granted Patent B2
US 12,507,920 · App. 17/426,497 · Granted Dec 30, 2025

Stabilizing matrices for implantable electrochemical biosensors

Inventors: Arati Sridharan (Chandler, AZ); Jitendran Muthuswamy (Chandler, AZ)
Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
A61B5/1473A61B5/0537A61B5/0538A61B5/6868
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,507,920
App. No.
17/426,497
Granted
Dec 30, 2025
Kind
B2
Abstract

A soft conductive composite composition can include a soft matrix containing a conductive member that is associated with a bioactive component. The soft matrix can be formed from a silicone composition. The conductive member can be carbon nanotubes in the silicone composition. The carbon nanotubes can have at least two walls and be conductive. Also, the carbon nanotubes can be a mixture of functionalized carbon nanotubes and non-functionalized carbon nanotubes, which mixture can have a ratio of 1:2 to 1:20 w/w of functionalized to non-functionalized carbon nanotubes per gram of the silicone composition. The bioactive component (e.g., enzyme) can be associated with at least a first portion of the carbon nanotubes. A second portion of the carbon nanotubes can be devoid of the bioactive component.

Claims (99)

1 . A system, comprising:

an electrochemical biosensor,

the electrochemical biosensor comprising a soft conductive composite composition comprising:

a silicone composition having an elastic modulus between 2 kPa and 9 kPa;

a bioactive component; and

carbon nanotubes in the silicone composition,

wherein:

the carbon nanotubes have at least 2 walls and the carbon nanotubes comprise a first plurality of carbon nanotubes modified by a first functional group and a second plurality of carbon nanotubes modified by the bioactive component;

the first plurality of carbon nanotubes and the second plurality of carbon nanotubes are at a ratio of 1:2 to 1:20 w/w;

the bioactive component is capable of performing a biochemical reaction with a substrate utilizing the second plurality of carbon nanotubes; and

the first functional group is selected from the group consisting of carboxylic acid, alkanes, alkenes, alkynes, amides, hydrides, heterocycles, transition metal oxides, peptides, DNAs, RNAs, and proteins.

2 . The system of claim 1 , having a characteristic selected from the group consisting of:

the ratio being 1:10 w/w of the first plurality of carbon nanotubes to the second plurality of carbon nanotubes;

the carbon nanotubes having 2 to 50 walls;

the carbon nanotubes having a length of 5 μm to 100 μm; and

the carbon nanotubes having a resistivity of 1 kohms to 500 kohms across 1 cm length cylinder.

3 . The system of claim 1 , wherein the soft conductive composite composition has a characteristic selected from the group consisting of:

an elastic modulus and/or a short-term relaxation time-constant matched with a soft tissue of interest; and

a short-term relaxation time-constant of 2 to 30 seconds.

4 . The system of claim 1 , having a characteristic selected from the group consisting of:

the soft conductive composite composition being on at least part of a surface of an implantable medical device;

at least a portion of a non-implantable medical device being coated with the soft conductive composite composition; and

the soft conductive composite composition at least partially coating a metal material or doped semiconductor material.

5 . The system of claim 1 , wherein the soft conductive composite composition comprises an anti-inflammatory agent.

6 . The system of claim 1 , wherein the soft conductive composite composition has a biocompatible coating.

7 . The system of claim 1 , having a characteristic selected from the group consisting of:

the carbon nanotubes being present at 1 mg to 100 mg per 1 gram of the silicone composition;

the carbon nanotubes being present at less than 5% w/w of the silicone composition;

the first plurality of carbon nanotubes being coupled to carboxylic acid functional groups;

at least a portion of the carbon nanotubes not being associated with the bioactive component;

at least a portion of the second plurality of carbon nanotubes having the bioactive component adsorbed thereon; and

at least a portion of the second plurality of carbon nanotubes having the bioactive component covalently coupled thereto.

8 . The system of claim 1 , wherein the bioactive component is an enzyme.

9 . A method of making the system of claim 1 , the method comprising:

selecting a PDMS precursor;

selecting the carbon nanotubes to have the ratio of the first plurality of carbon nanotubes to the second plurality of carbon nanotubes;

adsorbing a bioactive agent onto at least a portion of the carbon nanotubes;

cross-linking the PDMS precursor to obtain the silicone composition; and

introducing the carbon nanotubes into the PDMS precursor and/or crosslinked PDMS to form the soft conductive composite composition.

10 . The method of claim 9 , further comprising coating the soft conductive composite composition onto at least a portion of a hard body, wherein the body includes metal portions and/or doped semiconductor portions.

11 . The method of claim 10 , further comprising at least one of:

degassing/de-bubbling the soft conductive composite composition;

dry incubating the body coated with the soft conductive composite composition;

curing the soft conductive composite composition onto the body; or

rinsing the soft conductive composite composition with deionized water;

passivating the soft conductive composite composition with a composition having: sodium chloride, sodium bicarbonate, sodium phosphate monobasic, magnesium chloride, and glucose in filtered, deionized water;

controlling the degree of crosslinking the PDMS precursor to obtain the elastic modulus; or

using a tuning curve for elasticity versus ratio of crosslinker to base to tune the elastic modulus to match an elastic modulus of a cortical brain, and with an elastic modulus of approximately 5±3 kPa with shear modulus of 1.2-1.4 kPa.

12 . The method of claim 9 , comprising:

obtaining a crosslinker to base curve for a crosslinker and a base PDMS precursor;

determining a desired elastic modulus and short-term relaxation time-constant;

determining an amount of crosslinker for an amount of base PDMS precursor; and

crosslinking the base PDMS precursor with the amount of crosslinker according to the curve to obtain the desired elastic modulus and short-term relaxation time-constant for the soft conductive composite composition.

13 . The method of claim 9 , comprising at least one of:

making the surface of the soft conductive composite composition hydrophilic;

coating the surface of the soft conductive composite composition with a hydrophilic coating;

incubating the soft conductive composite composition in a fluid having an osmolarity of brain; or

passivating the surface of the soft conductive composite composition for 24 hours.

14 . A method of measuring properties at a neural interface, the method comprising:

providing a neural probe comprising the system of claim 1 ;

implanting the neural probe having the soft conductive composite composition at a neural interface; and

measuring a property with the neural probe.

15 . The method of claim 14 , further comprising at least one of:

measuring stability of electro-chemical impedance;

performing neural recordings; or

performing electrochemical impedance spectroscopy with the neural probe.

16 . The method of claim 14 , further comprising at least one of:

incising dura for implantation of the neural probe;

placing gelfoam over the neural probe after implantation;

implanting the neural probe into a neural interface of brain; or

securing the neural probe onto a skull.

17 . The system of claim 1 , wherein the bioactive component is selected from the group consisting of glucose oxidase, glucose-1-dehydrogenase, hexokinase, lactate oxidase, pyruvate oxidase, pyrrole-quinolinequinone enzyme, catalase, horseradish peroxidase, neurotransmitter sensitive enzyme, polyphenol oxidase, glutamate oxidase, acetylcholinesterase, choline oxidase, protein receptor, extracellular matrix derived peptide, and/or nucleotide-based oligomer.

18 . A device, comprising:

a body; and

an electrochemical biosensor,

the electrochemical biosensor comprising a soft conductive composite composition,

wherein the soft conductive composite composition includes:

a silicone composition having an elastic modulus between 2 kPa and 9 kPa;

a bioactive component; and

carbon nanotubes in the silicone composition,

wherein:

the carbon nanotubes have at least 2 walls and the carbon nanotubes comprise a first plurality of carbon nanotubes modified by a first functional group and a second plurality of carbon nanotubes modified by the bioactive component;

the first plurality of carbon nanotubes and the second plurality of carbon nanotubes are at a ratio of 1:2 to 1:20 w/w;

the bioactive component is capable of performing a biochemical reaction with a substrate utilizing the second plurality of carbon nanotubes;

the first functional group is selected from the group consisting of carboxylic acid, alkanes, alkenes, alkynes, amides, hydrides, heterocycles, transition metal oxides, peptides, DNAs, RNAs, and proteins; and

the soft conductive composite composition coats at least a portion of the body.

19 . The device of claim 18 , wherein the soft conductive composite composition has a characteristic selected from the group consisting of:

the ratio being 1:10 w/w of the first plurality of carbon nanotubes to the second plurality of carbon nanotubes;

the carbon nanotubes having 2 to 50 walls;

the carbon nanotubes having a length of 5 μm to 100 μm; and

the carbon nanotubes having a resistivity of 1 kohms to 500 kohms across 1 cm length cylinder.

20 . The device of claim 18 , wherein the body is at least one selected from among a probe, an electrode, and an implant; or the body is configured for a removable insertion into a living organism.

21 . The device of claim 18 , wherein the soft conductive composite composition comprises an anti-inflammatory agent.

22 . The device of claim 18 , wherein the soft conductive composite composition has a biocompatible coating.

23 . The device of claim 18 , comprising insulation between a surface of the body and the soft conductive composite composition.

24 . The device of claim 18 , wherein the body comprises:

a metal selected from the group consisting of stainless steel, platinum, platinum-iridium, silver/silver-chloride, gold, and tungsten; or

a doped single-crystal or polycrystalline semiconductor or carbon.

25 . The device of claim 18 , wherein the bioactive component is selected from the group consisting of glucose oxidase, glucose-1-dehydrogenase, hexokinase, lactate oxidase, pyruvate oxidase, pyrrole-quinolinequinone enzyme, catalase, horseradish peroxidase, neurotransmitter sensitive enzyme, polyphenol oxidase, glutamate oxidase, acetylcholinesterase, choline oxidase, protein receptor, extracellular matrix derived peptide, and/or nucleotide-based oligomer.

Assignments (2)
CONFIRMATORY LICENSE Recorded Mar 25, 2025
From: ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 070613/0175 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2021
From: SRIDHARAN, ARATI; MUTHUSWAMY, JITENDRAN
To: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
Reel/Frame 057083/0467 →
Continuity (2)
Provisional Application 62799277 · Jan 31, 2019
Related Publication 20220095962A1 · Mar 31, 2022
References Cited (65)
US 5089112A · Skotheim et al. · 1992 [cited by applicant]
US 8815397B2 · Jiang · 2014 [cited by examiner]
US 20040111121A1 · Brown et al. · 2004 [cited by applicant]
US 20050075708A1 · O'Brien et al. · 2005 [cited by applicant]
US 20090038820A1 · Keefer · 2009 [cited by applicant]
US 20100144205A1 · Searfass · 2010 [cited by examiner]
US 20140127490A1 · Islam et al. · 2014 [cited by applicant]
US 20170292063A1 · Sturtevant · 2017 [cited by examiner]
US 20180001081A1 · Minev · 2018 [cited by examiner]
US 20180298221A1 · Swogger · 2018 [cited by examiner]
US 20210071238A1 · Palma · 2021 [cited by examiner]
CN 100406879 · 2008 [cited by examiner]
FR 3024982B1 · 2018 [cited by examiner]
WO WO2005075571A1 · 2005 [cited by examiner]
WO WO2007056372A2 · 2007 [cited by examiner]
WO WO2007086909A2 · 2007 [cited by examiner]
WO WO2008074087A1 · 2008 [cited by examiner]
WO WO2012145652A1 · 2012 [cited by examiner]
WO WO2018027117A1 · 2018 [cited by examiner]
Machine Translation of WO-2005075571, Patent Translate, pp. 1-37, printed on Jul. 12, 2024 (Year: 2007). [cited by examiner]
Machine Translation of CN 100406879, Patent Translate, pp. 1-12. printed on Aug. 11, 2025 (Year: 2008). [cited by examiner]
Machine Translation of FR-3024982-B1, Patent Translate, pp. 1-10. printed on Aug. 11, 2025 (Year: 2016). [cited by examiner]
United States Patent and Trademark Office; International Search Report and Written Opinion issued in Int'l Application No. PCT/US20/16188 dated Jun. 16, 2020; 14 pages. [cited by applicant]
Sridharan et al.; “Penetrating Microindentation of Hypersoft, Conductive Silicone Neural Interfaces in Vivo Reveals Significantly Lower Mechanical Stess”; MRS Adv. col. 4; No. 46-47; pp. 2551-2558; Sep. 17, 2019; 8 page… [cited by applicant]
Ahuja, T. et al., “Biomolecular immobilization on conducting polymers for biosensing applications”, Biomaterials, Oct. 20, 2006, pp. 791-805. [cited by applicant]
Alhadrami, H., “Biosensors: Classifications, medical applications, and future prospective”, Biotechnology and Applied Biochemistry, Nov. 23, 2017, pp. 497-508. [cited by applicant]
Armada, M. et al., “Preparation of biosensors based in a siloxane homopolymer with interacting ferrocenes for the amperometric detection of peroxides”, Sensors and Actuators B, Apr. 8, 2004, pp. 143-149. [cited by applicant]
Arslan, A. et al., “Immobilization of tyrosinase in polysiloxane/polypyrrole copolymer matrices”, International Journal of Biological Macromolecules, 2005, pp. 163-167. [cited by applicant]
Bazaka, K. et al., “Implantable Devices: Issues and Challenges”, Electronics, Dec. 21, 2012, pp. 1-34. [cited by applicant]
Cash, K. et al., “Nanosensors and nanomaterials for monitoring glucose in Diabetes”, NIH Public Access, Sep. 23, 2010, pp. 1-20. [cited by applicant]
Cinquin, P. et al., “A Glucose BioFuel Cell Implanted in Rats”, PLoS ONE, May 4, 2010, pp. 1-7, vol. 5. Issue 5. [cited by applicant]
Clark, J. et al., “Chronic microsensors for longitudinal, subsecond dopamine detection in behaving animals”, Nature Methods: Brief Communications, Dec. 27, 2009, pp. 126-132, vol. 7, No. 2. [cited by applicant]
Cordeiro, C. et al., “In vivo continuous and simultaneous monitoring of brain energy substrates with a multiplex amperometric enzyme-based biosensor device”, Biosensors and Bioelectronics, Oct. 16, 2014, pp. 677-686. [cited by applicant]
De Melo-Junior, M. et al., “Polysiloxane-polyvinyl alcohol discs as support for antibody immobilization: Ultra-structural and physical-chemical characterization”, Reactive & Functional Polymers, Aug. 30, 2007, pp. 315-3… [cited by applicant]
Garris, P. et al., “Different Kinetics Govern Dopaminergic Transmission in the Amygdala, Prefrontal Cortex, and Striatum: An in vivo Voltammetric Study”, The Journal of Neuroscience, Jan. 1994, pp. 442-450. [cited by applicant]
Guazzaroni, M. et al., “Layer-by-Layer coated tyrosinase: An efficient and selective synthesis of catechols”, Bioorganic & Medicinal Chemistry, Nov. 20, 2011, pp. 157-166. [cited by applicant]
Jeon, J. et al., “Electrochemical Detection of Neurotransmitters: Toward Synapse-based Neural Interfaces”, Biomedical Engineering Letters, 2016, pp. 123-133. [cited by applicant]
Jin, Z. et al., “Conductive Polymer-Coated Carbon Nanotubes To Construct Stretchable and Transparent Electrochemical Sensors”, Analytical Chemistry, Dec. 28, 2016, pp. 2032-2038. [cited by applicant]
Lee, J. et al., “Flexible electrochemical biosensors based on O [cited by applicant]
Li, J. et al., “Carbon nanotube/polymer composite electrodes for flexible, attachable electrochemical DNA sensors”, Biosensors and Bioelectronics, Apr. 23, 2015, pp. 414-419. [cited by applicant]
Li, Y. et al., “A disposable biosensor based on immobilization of laccase with silica spheres on the MWCNTs-doped screen-printed electrode”, Chemistry Central Journal, 2012, pp. 1-8. [cited by applicant]
Lillehoj, P. et al, “Rapid, Electrical Impedance Detection of Bacterial Pathogens Using Immobilized Antimicrobial Peptides”, Journal of Laboratory Automation, 2014, pp. 42-49, vol. 19(1). [cited by applicant]
Mannoor, M. et al., “Electrical detection of pathogenic bacteria via immobilized antimicrobial peptides”, PNAS, Nov. 9, 2010, pp. 19207-19212, vol. 107, No. 45. [cited by applicant]
Monosik, R. et al., “Biosensors—classification, characterization and new trends”, Acta Chimica Slovaca, 2012, pp. 109-120, vol. 5, No. 1. [cited by applicant]
Muller, A. et al., “Cell-based reporters reveal in vivo dynamics of dopamine and norepinephrine release in murine cortex”, Nature Methods, Oct. 26, 2014, pp. 1245-1255, vol. 11, No. 12. [cited by applicant]
Nagarale, R.K. et al., “Electrochemical properties of ferrocene modified polysiloxane/chitosan nanocomposite and its application to glucose sensor”, Electrochimica Acta, Jun. 12, 2009, pp. 6508-6514. [cited by applicant]
Niroula, J. et al., “Combined covalent and noncovalent carboxylation of carbon nanotubes for sensitivity enhancement of clinical immunosensors†”, ChemComm, 2016, pp. 13039-13042. [cited by applicant]
Njagi, J. et al., “Amperometric Detection of Dopamine in Vivo with an Enzyme Based Carbon Fiber Microbiosensor”, Analytical Chemistry, Feb. 1, 2010, pp. 989-996, vol. 82, No. 3. [cited by applicant]
Ozer, B. et al., “Amperometric enzyme electrode for free cholesterol determination prepared with cholesterol oxidase immobilized in poly(vinylferrocenium) film”, Enzyme and Microbial Technology, 2007, pp. 262-265. [cited by applicant]
Puentes-Camacho, D. et al., “Functionalization of multiwalled carbon nanotubes by microwave irradiation for lysozyme attachment: comparison of covalent and adsorption methods by kinetics of thermal inactivation”, Advanc… [cited by applicant]
Reuillard, B. et al., “Direct electron transfer between tyrosinase and multi-walled carbon nanotubes for bioelectrocatalytic oxygen reduction”, Electrochemistry Communications, Apr. 5, 2012, pp. 19-22. [cited by applicant]
Rocchitta, G. et al., “Enzyme Biosensors for Biomedical Applications: Strategies for Safeguarding Analytical Performances in Biological Fluids”, Sensors, May 30, 2016, pp. 1-21. [cited by applicant]
Rodeberg, N. et al., “Hitchhiker's Guide to Voltammetry: Acute and Chronic Electrodes for in Vivo Fast-Scan Cyclic Voltammetry”, ACS Chemical Neuroscience, Jan. 27, 2017, pp. 221-234. [cited by applicant]
Sasso, S. et al., “Electropolymerized 1,2-Diaminobenzene as a Means To Prevent Interferences and Fouling and To Stabilize Immobilized Enzyme in Electrochemical Biosensors”, Analytical Chemistry, Jun. 1, 1990, pp. 1111-1… [cited by applicant]
Sen, S. et al., “Synthesis and Characterization of Polyvinylferrocene/Polypyrrole Composites”, Journal of Macromolecular Science, Part A: Pure and Applied Chemistry, 2008, pp. 485-494. [cited by applicant]
Singh, Y. et al., “Head-to-Head Comparisons of Carbon Fiber Microelectrode Coatings for Sensitive and Selective Neurotransmitter Detection by Voltammetry”, Analytical Chemistry, Jul. 19, 2011, pp. 6658-6666. [cited by applicant]
Tingry, S. et al., “Carbon paste biosensor for phenol detection of impregnated tissue: modification of selectivity by using β-cyclodextrin-containing PVA membrane”, Materials Science and Engineering C 26, Dec. 13, 2005,… [cited by applicant]
Tolosa, V. et al., “Electrochemically deposited iridium oxide reference electrode integrated with an electroenzymatic glutamate sensor on a multielectrode array microprobe”, Biosensors and Bioelectronics, Nov. 6, 2012, … [cited by applicant]
Vaddiraju, S. et al., “Emerging Synergy between Nanotechnology and Implantable Biosensors: A Review”, NIH Public Access, Mar. 15, 2010, pp. 1-28. [cited by applicant]
Walcarius, A., “Electrochemical Applications of Silica-Based Organic-Inorganic Hybrid Materials”, Chemistry of Materials, 2001, pp. 3351-3372, vol. 13, No. 10. [cited by applicant]
Wang, Z. et al., “Carbon nanomaterial-based electrochemical biosensors: an overview”, Nanoscale, 2015, pp. 6240-6431. [cited by applicant]
Wilson, G. et al., “Biosensors for real-time in vivo measurements”, Biosensors and Bioelectronics, Jan. 15, 2005, pp. 2388-2403. [cited by applicant]
Xu, J. et al., “A modularized and flexible sensor based on MWCNT/PDMS composite film for on-site electrochemical analysis”, Journal of Electroanalytical Chemistry, Oct. 17, 2017, pp. 68-74. [cited by applicant]
Zebda, A. et al., “Single Glucose Biofuel Cells Implanted in Rats Power Electronic Devices”, Scientific Reports, Mar. 22, 2013, pp. 1-5. [cited by applicant]
Zimmerman, J. et al., “Simultaneous Electrochemical Measurements of Oxygen and Dopamine in Vivo”, Analytical Chemistry, Jan. 1, 1991, pp. 24-28, vol. 63, No. 1. [cited by applicant]